Showing results (1701-1710 of 3,085) with videos related to
Sort By:
Pageof 309
Drug Safety|June 18, 2009
Risk of fractures with glitazones: a critical review of the evidence to dateMichael Bodmer, Christian Meier, Marius E Kraenzlin, et al.Drug Safety|June 18, 2009
Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptationChantal Schlatter, Sabin S Egger, Lydia Tchambaz, et al.Drug Safety|June 18, 2009
Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System DatabaseCatherine Do, Eric Huyghe, Maryse Lapeyre-Mestre, et al.Drug Safety|June 18, 2009
Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphologyClaus Graff, Mads P Andersen, Joel Q Xue, et al.Drug Safety|May 8, 2009
Safety profile of the respiratory fluoroquinolone moxifloxacin: comparison with other fluoroquinolones and other antibacterial classesFrançoise Van Bambeke, Paul M TulkensDrug Safety|May 8, 2009
Patch testing for the diagnosis of anticonvulsant hypersensitivity syndrome: a systematic reviewAbdelbaset A Elzagallaai, Sandra R Knowles, Michael J Rieder, et al.Drug Safety|September 3, 2009
Public perceptions of the pharmaceutical industry and drug safety: implications for the pharmacovigilance professional and the culture of safetyAxel K Olsen, Matthew D WhalenDrug Safety|September 3, 2009
Evaluation of abuse and dependence on drugs used for self-medication: a pharmacoepidemiological pilot study based on community pharmacies in FranceLudivine Orriols, Julia Gaillard, Maryse Lapeyre-Mestre, et al.Drug Safety|August 13, 2009
Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospitalKuntheavy Ing-Lorenzini, Jules Desmeules, Olivier Plachta, et al.Pageof 309